163 related articles for article (PubMed ID: 21945910)
21. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent.
Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z
Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047
[TBL] [Abstract][Full Text] [Related]
22. Development of Denticap, a matrix based sustained release formulation for treatment of toothache, dental infection and other gum problem.
Mukherjee B; Roy G; Ghosh S
Curr Drug Deliv; 2009 Apr; 6(2):199-207. PubMed ID: 19450227
[TBL] [Abstract][Full Text] [Related]
23. A novel zein-based dry coating tablet design for zero-order release.
Guo HX; Shi YP
Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
[TBL] [Abstract][Full Text] [Related]
24. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
26. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
[TBL] [Abstract][Full Text] [Related]
28. Development of pulsatile release tablets with swelling and rupturable layers.
Sungthongjeen S; Puttipipatkhachorn S; Paeratakul O; Dashevsky A; Bodmeier R
J Control Release; 2004 Mar; 95(2):147-59. PubMed ID: 14980764
[TBL] [Abstract][Full Text] [Related]
29. [Preparation and evaluation of press-coated aminophylline tablet using crystalline cellulose and polyethylene glycol in the outer shell for timed-release dosage forms].
Watanabe Y; Mukai B; Kawamura K; Ishikawa T; Namiki M; Utoguchi N; Fujii M
Yakugaku Zasshi; 2002 Feb; 122(2):157-62. PubMed ID: 11857956
[TBL] [Abstract][Full Text] [Related]
30. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
Li CJ; Zhu JB; Yu WY
Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
[TBL] [Abstract][Full Text] [Related]
31. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
32. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent.
Rao VM; Zannou EA; Stella VJ
J Pharm Sci; 2011 Apr; 100(4):1576-87. PubMed ID: 24081477
[TBL] [Abstract][Full Text] [Related]
33. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
34. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
Ishida M; Abe K; Hashizume M; Kawamura M
Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
[TBL] [Abstract][Full Text] [Related]
35. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
36. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
37. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
[TBL] [Abstract][Full Text] [Related]
38. Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
Chen K; Chang HHR; Shalviri A; Li J; Lugtu-Pe JA; Kane A; Wu XY
Eur J Pharm Biopharm; 2017 Nov; 120():116-125. PubMed ID: 28887098
[TBL] [Abstract][Full Text] [Related]
39. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of gastric retenting and chronopharmacologic drug delivery tablets of sinomenine hydrochloride].
Zhang Y; Wu Y; Geng Y; Peng X
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):554-9. PubMed ID: 19526781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
